Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8938 |
High Similarity |
NPD3749 |
Approved |
0.8773 |
High Similarity |
NPD6959 |
Discontinued |
0.8599 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8466 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8393 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8365 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8314 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8293 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8282 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8269 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8263 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8235 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8217 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8193 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8187 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8182 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8176 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8166 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8165 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8153 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8153 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8121 |
Intermediate Similarity |
NPD1934 |
Approved |
0.811 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8084 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8075 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8072 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8063 |
Intermediate Similarity |
NPD2309 |
Approved |
0.8035 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8025 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8025 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8025 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8025 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7976 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7975 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7975 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7975 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7939 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7937 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7929 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7929 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7927 |
Intermediate Similarity |
NPD920 |
Approved |
0.7911 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7907 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7889 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7874 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7805 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7805 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7784 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7764 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7716 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7709 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7709 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7688 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7688 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7688 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7684 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7683 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7643 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD5408 |
Approved |
0.764 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.764 |
Intermediate Similarity |
NPD5406 |
Approved |
0.764 |
Intermediate Similarity |
NPD5404 |
Approved |
0.764 |
Intermediate Similarity |
NPD5405 |
Approved |
0.764 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.764 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7636 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7628 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7619 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7609 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7598 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7596 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7588 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.758 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7572 |
Intermediate Similarity |
NPD919 |
Approved |
0.7571 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7556 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7556 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7544 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7544 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7543 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7543 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7543 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7532 |
Intermediate Similarity |
NPD4749 |
Approved |
0.75 |
Intermediate Similarity |
NPD5402 |
Approved |
0.75 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7486 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7459 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7453 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7438 |
Intermediate Similarity |
NPD943 |
Approved |
0.7421 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7421 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7396 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7374 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7348 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7345 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7337 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.733 |
Intermediate Similarity |
NPD6779 |
Approved |
0.733 |
Intermediate Similarity |
NPD6776 |
Approved |
0.733 |
Intermediate Similarity |
NPD6780 |
Approved |
0.733 |
Intermediate Similarity |
NPD6781 |
Approved |
0.733 |
Intermediate Similarity |
NPD6777 |
Approved |
0.733 |
Intermediate Similarity |
NPD6778 |
Approved |
0.733 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7325 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7312 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7294 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7268 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7268 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7256 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7249 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7249 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7246 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7216 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7216 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7216 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7216 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7215 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7205 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7191 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7184 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7184 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7184 |
Intermediate Similarity |
NPD37 |
Approved |
0.7182 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7179 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7176 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7175 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7167 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7159 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7159 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7159 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7134 |
Intermediate Similarity |
NPD1608 |
Approved |
0.712 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.712 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7111 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7102 |
Intermediate Similarity |
NPD5616 |
Clinical (unspecified phase) |
0.7102 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7099 |
Intermediate Similarity |
NPD411 |
Approved |
0.7081 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7077 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7073 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7071 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.707 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7068 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7068 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7062 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7056 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.705 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7048 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7045 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7033 |
Intermediate Similarity |
NPD3446 |
Phase 1 |
0.7029 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7025 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7019 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7012 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7011 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6995 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6989 |
Remote Similarity |
NPD7577 |
Discontinued |
0.6983 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD2654 |
Approved |
0.6975 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.697
|
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |